therapeutic action: treatment of fungal infections

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

Dr. John Perfect shares decades of experience treating fungal infections and developing antifungal medications. He discusses how treatments have evolved from highly toxic drugs to more effective options, but notes that fungal infections remain challenging, especially when patients develop resistance or have serious underlying diseases. He emphasizes the importance of combining drugs with immune therapies and shorter, more potent treatments rather than lengthy medication courses. Despite challenges, Dr. Perfect is optimistic about the future of medicine and encourages young scientists to pursue careers in this field.

Read More »

Itraconazole resistance in Madurella fahalii linked to a distinct homolog of the gene encoding cytochrome P450 14-α sterol demethylase (CYP51)

A fungal infection called mycetoma caused by Madurella fahalii doesn’t respond to a common antifungal drug called itraconazole. Researchers discovered that this fungus has an extra gene that produces a protein that resists the drug, which isn’t found in a similar fungus that remains susceptible. This finding could help develop better treatments for mycetoma patients in the future.

Read More »
Scroll to Top